IMAX CORP (IMAX) stock intrinsic value fair value estimate & owner earnings analysis

IMAX is the global leader in large-format, premium theatrical cinema. It licenses its projection and sound technology to exhibitors worldwide, converts major film releases into its proprietary format (IMAX DMR), and increasingly funds and part-owns theater systems directly through joint revenue-sharing arrangements with exhibitors, taking a share of box office receipts in exchange for paying for the equipment. The business is inherently tied to the cadence of the film industry's biggest event releases and to global box office health, which has made its results volatile - never more so than during the pandemic-era theater closures of 2020-2021. We anchor the value of the business on the median of owner earnings per share (cash generated by operations, less the reinvestment needed to sustain the theater network, less stock compensation, and stripped of working-capital timing swings) across eight years spanning 2016 through 2025, deliberately excluding 2020 and 2021 as a one-time global shutdown rather than a representative down cycle. That anchor is roughly $0.72 per share. The most recent three years (2023, 2024 and 2025) came in well above that - $1.00, $0.94 and $1.40 per share respectively - reflecting a network that has grown internationally, shifted toward higher-margin laser projection systems, and captured a larger share of a recovering box office. Our forward outlook starts between the longer-run median and the recent run-rate rather than simply extrapolating the strongest recent year. One accounting judgment worth flagging: IMAX funds much of its theater network by paying for equipment installed under joint revenue-sharing arrangements with exhibitors - cash that sits outside the standard "purchase of property and equipment" line because IMAX discloses it as its own line item. We identified this spending (roughly $7 million to $45 million a year over the period) and included it as real capital investment, split between what's needed to sustain today's network and what's funding growth, exactly as we would any other capital expenditure. Leaving it out would have overstated the cash this business can generate for owners. We valued the company over an explicit ten-year forecast plus a view of what follows, discounted at a flat 6% - the rate we use for every company, so that risk shows up in the spread between scenarios rather than in the discount rate. Our base case assumes owner earnings grow at a moderate, mid-single-digit pace as the network keeps expanding internationally (particularly in China and other growth markets) and margins benefit from the ongoing shift to laser systems, before settling into a mature, self-sustaining level once the network stops expanding - it doesn't need to keep growing in real terms to hold its value, because the spending required to renew it is already charged as a cost, not treated as free cash. That produces a value of roughly $23 per share, with the years beyond the ten-year forecast accounting for a little under two-thirds of that total. Our bull case assumes a stronger, more consistent run of major event-film releases (the kind of tentpole slate that drives outsized results in IMAX's best years), faster international network growth, and continued margin gains, sustaining high-single-digit growth for a decade. That comes out to roughly $43 per share. Our bear case is the one we'd flag most. It assumes streaming increasingly erodes the economics of theatrical exhibition over time - shorter theatrical windows, more mid-tier films skipping cinemas entirely, and exhibitor partners under sustained financial pressure - combined with a Chinese box office market that stops growing and some margin pressure from a shifting equipment mix. In this case, owner earnings stay pinned near the weakest levels IMAX has actually reported in a normal (non-pandemic) year and gradually erode rather than grow. That scenario is worth only around $5 per share. The wide gap between our bear case and the other two reflects a real risk we take seriously: that streaming continues to compress the economics of theatrical moviegoing over the next decade. It is not a remote tail risk in our view, and it deserves real weight in setting the margin-of-safety price. That calls for a large margin of safety, putting the margin-of-safety price at roughly $11.50 per share. A few other notes for readers. IMAX carries about $259 million of low-coupon convertible notes due 2030 (refinanced in 2025); that leverage is modest relative to the size of the business and shows up mainly as a mild drag in the bear case rather than as a standalone risk. The company also owns roughly 72% of a separately-listed China subsidiary, which gives it real exposure to Chinese box office and regulatory conditions - we've reflected that as a driver within the bear case rather than treating it as disqualifying, since the parent company is not Chinese-controlled. We found no indication of a going-concern issue, delisting risk, or any other disqualifying business characteristic.